30
Participants
Start Date
March 10, 2020
Primary Completion Date
August 4, 2020
Study Completion Date
August 15, 2020
0.5mg AZ-010
Subject will receive a single inhaled dose (0.5mg) of AZ-010 or matching Staccato Placebo
1mg AZ-010
Subject will receive a single inhaled dose (1mg) of AZ-010 or matching Staccato Placebo
3mg AZ-010
Subject will receive a single inhaled dose (3mg) of AZ-010 or matching Staccato Placebo
Celerion, Tempe
Lead Sponsor
Collaborators (1)
Celerion
INDUSTRY
Alexza Pharmaceuticals, Inc.
INDUSTRY